Carson Wealth (CWM LLC)
RLAY icon

Carson Wealth (CWM LLC)’s Relay Therapeutics RLAY Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$696K Buy
69,959
+2,356
+3% +$21.1K ﹤0.01% 1786
2025
Q4 		$572K Sell
67,603
-325
-0.5% -$2.32K ﹤0.01% 1834
2025
Q3 		$355K Buy
67,928
+10,935
+19% +$41.7K ﹤0.01% 1997
2025
Q2 		$197K Buy
56,993
+36,724
+181% +$109K ﹤0.01% 2188
2025
Q1 		$53K Buy
20,269
+15,944
+369% +$62.5K ﹤0.01% 2943
2024
Q4 		$18K Buy
4,325
+3,455
+397% +$18.8K ﹤0.01% 3525
2024
Q3 		$6K Buy
870
+24
+3% +$179 ﹤0.01% 4038
2024
Q2 		$6K Buy
846
+823
+3,578% +$5.62K ﹤0.01% 3803
2024
Q1 		$0 Buy
+23
New +$224 ﹤0.01% 4684
2023
Q4 		– Sell
-21
Closed – – 4465
2023
Q3 		$0 Sell
21
-470
-96% -$5.05K ﹤0.01% 4488
2023
Q2 		$6K Buy
+491
New +$6.11K ﹤0.01% 3372
2022
Q4 		– Sell
-136
Closed -$3K – 4211
2022
Q3 		$3K Buy
136
+109
+404% +$2.39K ﹤0.01% 3357
2022
Q2 		$0 Buy
+27
New +$579 ﹤0.01% 4055

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RLAY Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Relay Therapeutics (RLAY) stake by 3.5% in Q1 2026, buying an estimated $21.1K and bringing the position to 69,959 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #1786.

Carson Wealth (CWM LLC) first reported a position in RLAY in Q2 2022 and has held it in 13 quarters since. 243 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Carson Wealth (CWM LLC) held 69,959 shares of Relay Therapeutics worth $696K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 2,356 Relay Therapeutics shares in Q1 2026, an estimated $21.1K.
  • Relay Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1786 holding.
  • Carson Wealth (CWM LLC) first reported a position in Relay Therapeutics in Q2 2022 and has held it in 13 quarters since.
  • 243 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.